Description

Embolotherapy is a type of endovascular treatment that aims to occlude abnormal blood vessels in order to control bleeding, close fistulae or arteriovenous malformations, devascularise organs, reduce tumours and much more. To accomplish occlusion, embolotherapy uses minimally-invasive techniques and various embolic agents, such as gelfoam, coils, balloons and angiographic catheters to achieve precise and significant results. The global embolotherapy market is set to grow by US$ 1.50 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 6.6% during the forecast period, according to data and analytics company StrategyHelix. Growing target population, expanding applications of embolotherapy devices, escalating prevalence of chronic and lifestyle-associated diseases, increasing healthcare expenditure, and improving healthcare infrastructure are expected to boost the market growth in the coming years.

The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for embolotherapy. The global embolotherapy market is segmented on the basis of product, indication, procedure, region, and end user. By product, it is categorized into embolic agents, and support devices. The embolic agents segment held the largest market share in 2020. By indication, the embolotherapy market is divided into cancer, neurological diseases, peripheral vascular diseases, urological and nephrological disorders, and gastrointestinal disorders. The cancer segment accounted for the largest market share in 2020. Based on procedure, the embolotherapy market is divided into transcatheter arterial embolization, transarterial chemoembolization, and transarterial radioembolization/selective internal radiation therapy. Embolotherapy market by region is divided into North America, Asia Pacific, Europe, and Rest of the World (ROW).

The report has profiled some of the key players of the market such as Acandis GmbH, Balt Extrusion SAS, Boston Scientific Corporation, Cook Group Incorporated, Guerbet SA, Johnson & Johnson, Kaneka Corporation, Medtronic plc, Meril Life Sciences Private Limited, Merit Medical Systems Inc., Penumbra Inc., Sirtex Medical Limited, Stryker Corporation, Terumo Corporation.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the embolotherapy market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: embolic agents, and support devices
Indication: cancer, neurological diseases, peripheral vascular diseases, urological and nephrological disorders, and gastrointestinal disorders
Procedure: transcatheter arterial embolization, transarterial chemoembolization, and transarterial radioembolization/selective internal radiation therapy
End user: hospitals and clinics, ambulatory surgical centers (ascs), and others
Region: North America, Asia Pacific, Europe, and Rest of the World (ROW)
Years Considered: this report covers the period 2017 to 2027

Key Benefits for Stakeholders

Get a comprehensive picture of the global embolotherapy market
Identify regional strategies and strategic priorities on the basis of local data and analysis
Pinpoint growth sectors and trends for investment
Understand what the future of the global embolotherapy market looks like
Identify the competitive landscape and window of opportunity

Table of Contents

1. Market Definition
2. Research Methodology
3. Market Data & Outlook
3.1 Market Value
3.2 Market Value Forecast
4. Embolotherapy Market by Product
4.1 Embolic Agents
4.2 Support Devices
5. Embolotherapy Market by Indication
5.1 Cancer
5.2 Neurological Diseases
5.3 Peripheral Vascular Diseases
5.4 Urological And Nephrological Disorders
5.5 Gastrointestinal Disorders
6. Embolotherapy Market by Procedure
6.1 Transcatheter Arterial Embolization
6.2 Transarterial Chemoembolization
6.3 Transarterial Radioembolization/Selective Internal Radiation Therapy
7. Embolotherapy Market by Region
7.1 North America
7.2 Asia Pacific
7.3 Europe
7.4 Rest Of The World (Row)
8. Embolotherapy Market by End User
8.1 Hospitals And Clinics
8.2 Ambulatory Surgical Centers (Ascs)
8.3 Others
9. Company Profiles
9.1 Acandis GmbH
9.2 Balt Extrusion SAS
9.3 Boston Scientific Corporation
9.4 Cook Group Incorporated
9.5 Guerbet SA
9.6 Johnson & Johnson
9.7 Kaneka Corporation
9.8 Medtronic plc
9.9 Meril Life Sciences Private Limited
9.10 Merit Medical Systems Inc.
9.11 Penumbra, Inc.
9.12 Sirtex Medical Limited
9.13 Stryker Corporation
9.14 Terumo Corporation
10. Appendix
10.1 About StrategyHelix
10.2 Disclaimer